MabVax Therapeutics Holdings Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$10.04 |
Market Cap |
$4.03 M |
Shares Outstanding |
8.96 M |
Public Float |
8.19 M |
Address |
11535 Sorrento Valley Road San Diego California 92121 United States |
Employees | - |
Website | http://www.mabvax.com |
Updated | 09/14/2018 |
MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA. . |